Publications (158) Javier Arbizu Lostao publications

filter_list

2025

  1. Clinical Research on Positron Emission Tomography Imaging of the Neuro-Stimulation System in Patients with Cochleo-Vestibular Implants: Is There a Response Beyond the Peripheral Organ?

    Journal of Clinical Medicine, Vol. 14, Núm. 5

  2. Combination of amyloid and FDG PET for the prediction of short-term conversion from MCI to Alzheimer´s disease in the clinical practice

    European Journal of Nuclear Medicine and Molecular Imaging

  3. The basics of PET molecular imaging in neurodegenerative disorders with dementia and/or parkinsonism

    European Radiology

  4. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

    Alzheimer's and Dementia, Vol. 21, Núm. 1

2024

  1. Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis

    Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574

  2. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 7, pp. 1891-1908

2023

  1. Case-Based Guide for Image Interpretation and Reporting

    Molecular Imaging of Neurodegenerative Disorders (Springer International Publishing), pp. 255-334

  2. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 8, pp. 2486-2500

  3. Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 1035-1047

2022

  1. Update on the diagnosis of encephalitis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 4, pp. 247-257

2021

  1. Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia

    Journal of Neurology

  2. Case 11: Corticobasal Syndrome: [18F]FDG and Amyloid PET

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 55-58

  3. Case 14: Creutzfeldt–Jakob Disease with Pathological Confirmation

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 69-73

  4. Case 20: Autoimmune Encephalitis with Unusual Antibodies

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 99-103

  5. Case 29: Primary Brain Lymphoma

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 141-145

  6. Case 2: Alzheimer’s Disease—[18F] FDG, Tau, and Amyloid PET

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 9-13

  7. Case 9: Progressive Supranuclear Palsy: Richardson Syndrome and Parkinsonian Variants

    Clinical Nuclear Medicine in Neurology: an Atlas of Challenging Cases (Springer International Publishing), pp. 45-50

  8. Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis

    Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472

  9. Finding our way through the labyrinth of dementia biomarkers

    European Journal of Nuclear Medicine and Molecular Imaging

  10. [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 947-948